Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 13.11%25.19B | -0.52%89.17B | 20.61%22.27B | 26.53%89.64B | 14.13%19.53B | 67.50%29.11B | 22.57%22.53B | 2.75%18.47B | -3.88%70.85B | -7.31%17.11B |
| Net interest income | 19.45%12.28B | 24.65%40.66B | 16.35%10.28B | 7.00%32.62B | 26.46%7.93B | 7.04%8.6B | 1.03%7.26B | -1.80%8.83B | -5.02%30.48B | -14.44%6.27B |
| -Total interest income | 36.97%16.68B | 23.44%50.78B | 6.02%12.18B | 12.78%41.13B | 10.41%9.48B | 2.52%10.32B | 18.38%9.85B | 20.87%11.48B | 10.16%36.47B | 12.56%8.58B |
| -Total interest expense | 131.82%4.4B | 18.82%10.12B | -28.40%1.9B | 42.13%8.52B | -32.97%1.55B | -15.25%1.73B | 128.65%2.59B | 423.91%2.65B | 487.55%5.99B | 669.77%2.32B |
| Non interest income | 7.68%12.92B | -14.92%48.51B | 24.52%12B | 41.27%57.02B | 7.00%11.6B | 119.43%20.52B | 36.40%15.27B | 7.31%9.63B | -2.99%40.37B | -2.62%10.84B |
| -Fees and commissions | 4.16%2.03B | 4.60%10.54B | 1.88%1.95B | 0.27%10.07B | 2.94%3.08B | 0.51%2.55B | 1.56%2.54B | -5.59%1.91B | 6.85%10.05B | 16.60%2.99B |
| -Including:Fees and commission income | 7.33%3.18B | 6.37%14.03B | 2.39%2.96B | 1.77%13.19B | 1.48%3.72B | 3.20%3.06B | 3.13%3.52B | -0.93%2.89B | 4.22%12.96B | 9.87%3.66B |
| -Including:Fees and commission expense | 13.41%1.15B | 12.10%3.49B | 3.36%1.01B | 6.93%3.12B | -5.09%634M | 18.94%515M | 7.41%986M | 9.61%981M | -3.92%2.91B | -12.68%668M |
| -Total other operating income | 8.36%10.89B | -19.11%37.98B | 30.11%10.05B | 54.85%46.95B | 8.55%8.52B | 163.60%17.97B | 46.41%12.73B | 11.06%7.72B | -5.87%30.32B | -8.38%7.85B |
| Credit losses provision | -82.23%617M | 152.40%3.47B | -39.06%1.38B | |||||||
| Operating expense | 8.95%17.88B | -5.58%67.65B | 14.31%16.41B | 23.59%71.65B | -8.12%12.86B | 70.91%24.09B | 31.80%20.35B | -0.62%14.36B | 4.04%57.98B | -4.61%13.99B |
| Selling and administrative expenses | 7.23%8.07B | 0.14%31.07B | -2.21%7.53B | 0.36%31.03B | 4.52%7.91B | -0.90%7.73B | -0.08%7.7B | -1.96%7.7B | -4.09%30.92B | -4.57%7.56B |
| -General and administrative expense | 7.23%8.07B | 0.14%31.07B | -2.21%7.53B | 0.36%31.03B | 4.52%7.91B | -0.90%7.73B | -0.08%7.7B | -1.96%7.7B | -4.09%30.92B | -4.57%7.56B |
| Other operating expenses | 10.41%9.81B | -9.95%36.58B | 33.40%8.89B | 50.14%40.62B | -23.00%4.95B | 159.92%16.36B | 63.55%12.65B | 0.97%6.66B | 15.20%27.06B | -4.67%6.43B |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 2,650.00%255M | -19,800.00%-197M | -600.00%-10M | 107.69%1M | 66.67%-1M | 0 | 0 | 2M | -103.85%-13M | 90.63%-3M |
| Less:Other special charges | -2,650.00%-255M | 12,500.00%124M | 600.00%10M | -107.69%-1M | -66.67%1M | --0 | --0 | ---2M | -65.79%13M | -90.63%3M |
| Less:Write off | ---- | --73M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 29.37%7.57B | 42.64%20.7B | 42.30%5.85B | 26.40%14.51B | 84.09%3.19B | 53.11%5.03B | -25.75%2.18B | 16.62%4.11B | -28.50%11.48B | 15.98%1.74B |
| Income tax | 30.63%2.33B | 33.37%5.97B | 53.30%1.79B | 44.23%4.48B | 95.38%1.06B | 82.51%1.63B | 16.54%627M | 2.82%1.17B | -29.15%3.1B | 15.85%541M |
| Net income | 28.85%5.24B | 46.77%14.73B | 37.96%4.06B | 19.80%10.04B | 79.21%2.14B | 42.13%3.4B | -35.25%1.56B | 23.17%2.95B | -28.27%8.38B | 15.83%1.19B |
| Net income continuous operations | 28.81%5.24B | 46.78%14.73B | 37.95%4.06B | 19.79%10.04B | 78.98%2.14B | 42.13%3.4B | -35.22%1.56B | 23.16%2.95B | -28.26%8.38B | 16.03%1.19B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 28.85%5.24B | 46.77%14.73B | 37.96%4.06B | 19.80%10.04B | 79.21%2.14B | 42.13%3.4B | -35.25%1.56B | 23.17%2.95B | -28.05%8.38B | 15.60%1.19B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 28.85%5.24B | 46.77%14.73B | 37.96%4.06B | 19.80%10.04B | 79.21%2.14B | 42.13%3.4B | -35.25%1.56B | 23.17%2.95B | -28.05%8.38B | 15.60%1.19B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 29.91%106.4533 | 50.93%298.9133 | 42.49%81.9467 | 22.76%198.0433 | 85.56%42.82 | 45.52%67.0967 | -34.01%30.6167 | 25.71%57.51 | -25.46%161.3267 | 12.24%23.0767 |
| Diluted earnings per share | 29.91%106.4533 | 50.93%298.9133 | 42.49%81.9467 | 22.86%198.0433 | 85.08%42.7111 | 45.52%67.0967 | -34.15%30.534 | 26.04%57.51 | -25.33%161.2 | 12.55%23.0767 |
| Dividend per share | 0 | 50.00%90 | 0 | 50.00%60 | 66.67%33.3333 | 0 | 33.33%26.6667 | 0 | 0.00%40 | -25.00%20 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |